Cargando…

Comparison of prediction methods for treatment continuation of antipsychotics in children and adolescents with schizophrenia

OBJECTIVE: There is little evidence for finding optimal antipsychotic treatment for schizophrenia, especially in paediatrics. To evaluate the performance and clinical benefit of several prediction methods for 1-year treatment continuation of antipsychotics. DESIGN AND SETTINGS: Population-based prog...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jeon, Soo Min, Cho, Jaehyeong, Lee, Dong Yun, Kwon, Jin-Won
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2022
Materias:	Digital Mental Health
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9811082/ https://www.ncbi.nlm.nih.gov/pubmed/35418448 http://dx.doi.org/10.1136/ebmental-2021-300404

Ejemplares similares

Randomised controlled trial of gradual antipsychotic reduction and discontinuation in people with schizophrenia and related disorders: the RADAR trial (Research into Antipsychotic Discontinuation and Reduction)
por: Moncrieff, Joanna, et al.
Publicado: (2019)

Digital health interventions to improve adherence to oral antipsychotics among patients with schizophrenia: a scoping review
por: Wu, Tao, et al.
Publicado: (2023)

App-based guided problem-solving intervention for adolescent mental health: a pilot cohort study in Indian schools
por: Gonsalves, Pattie P, et al.
Publicado: (2021)

Critical appraisal and comparison of recommendations of clinical practice guidelines for treatment of schizophrenia in children and adolescents: a methodological survey protocol
por: Alves, Maíra Ramos, et al.
Publicado: (2020)

Evaluation of telepsychiatry during the COVID-19 pandemic across service users, carers and clinicians: an international mixed-methods study
por: Sheriff, Rebecca, et al.
Publicado: (2023)

Study protocol for the development and internal validation of Schizophrenia Prediction of Resistance to Treatment (SPIRIT): a clinical tool for predicting risk of treatment resistance to antipsychotics in first-episode schizophrenia
por: Farooq, Saeed, et al.
Publicado: (2022)

Can incentives improve antipsychotic adherence in major mental illness? A mixed-methods systematic review
por: Hodson, Nathan, et al.
Publicado: (2022)

Psychiatric comorbid disorders of cognition: a machine learning approach using 1175 UK Biobank participants
por: Li, Chenlu, et al.
Publicado: (2020)

Impact of COVID-19 on telepsychiatry at the service and individual patient level across two UK NHS mental health Trusts
por: Hong, James SW, et al.
Publicado: (2021)

Prediction of treatment dosage and duration from free-text prescriptions: an application to ADHD medications in the Swedish prescribed drug register
por: Zhang, Le, et al.
Publicado: (2021)

Guided digital health intervention for depression in Lebanon: randomised trial
por: Cuijpers, Pim, et al.
Publicado: (2022)

Increasing the value of digital phenotyping through reducing missingness: a retrospective review and analysis of prior studies
por: Currey, Danielle, et al.
Publicado: (2023)

Digital mental health: challenges and next steps
por: Smith, Katharine A, et al.
Publicado: (2023)

Efficacy of clozapine compared with other second-generation antipsychotic drugs in patients with treatment-resistant schizophrenia: protocol for a systematic review and individual patient data meta-analysis of randomised controlled trials
por: Siafis, Spyridon, et al.
Publicado: (2023)

Pharmacological guidelines for schizophrenia: a systematic review and comparison of recommendations for the first episode
por: Keating, Dolores, et al.
Publicado: (2017)

A method to advance adolescent sexual health research: Automated algorithm finds sexual history documentation
por: Robertson, Caryn, et al.
Publicado: (2022)

Risk of dyslipidaemia with antipsychotic drug treatment in Chinese inpatients with mental illness: a hospital-based cohort study
por: Ma, Qiuyue, et al.
Publicado: (2021)

User engagement in mobile apps for people with schizophrenia: A scoping review
por: Simões de Almeida, Raquel, et al.
Publicado: (2023)

Editorial: Continued opportunities in wearable technologies and physiological assessment
por: Navalta, James W., et al.
Publicado: (2023)

OCT and OCT Angiography Offer New Insights and Opportunities in Schizophrenia Research and Treatment
por: Green, Kyle M., et al.
Publicado: (2022)

Adjunctive agents to antipsychotics in schizophrenia: a systematic umbrella review and recommendations for amino acids, hormonal therapies and anti-inflammatory drugs
por: Fond, Guillaume, et al.
Publicado: (2023)

Prescribing pattern of antipsychotic medication for first-episode psychosis: a retrospective cohort study
por: Keating, Dolores, et al.
Publicado: (2021)

Impact of the COVID-19 pandemic on children and adolescents with autism spectrum disorder and their families: a mixed-methods study protocol
por: Dekker, Linda, et al.
Publicado: (2022)

Cognitive Impairments in Schizophrenia: A Study in a Large Clinical Sample Using Natural Language Processing
por: Mascio, Aurelie, et al.
Publicado: (2021)

Association of cannabis use with hospital admission and antipsychotic treatment failure in first episode psychosis: an observational study
por: Patel, Rashmi, et al.
Publicado: (2016)

Role of community pharmacists in the use of antipsychotics for behavioural and psychological symptoms of dementia (BPSD): a qualitative study
por: Maidment, Ian D, et al.
Publicado: (2016)

Use of second-generation antipsychotics in autism spectrum disorder: a systematic review and meta-analysis protocol
por: Lopes, Luis Phillipe Nagem, et al.
Publicado: (2023)

Clinical Validation of a Soft Wireless Continuous Blood Pressure Sensor During Surgery
por: Chou, En-Fan, et al.
Publicado: (2021)

Virtual monitoring in CF – the importance of continuous monitoring in a multi-organ chronic condition
por: Vagg, Tamara, et al.
Publicado: (2023)

Editorial: Digital health quality, acceptability, and cost: steps to effective continuity of cancer care
por: Singleton, Anna C., et al.
Publicado: (2023)

Screening for the metabolic side effects of antipsychotic medication: findings of a 6-year quality improvement programme in the UK
por: Barnes, T R E, et al.
Publicado: (2015)

Movement side effects of antipsychotic drugs in adults with and without intellectual disability: UK population-based cohort study
por: Sheehan, Rory, et al.
Publicado: (2017)

Feasibility of a pharmacist-led physical health monitoring for patients on antipsychotic medications: protocol for a longitudinal study
por: Bui, Tien Ngoc Thi, et al.
Publicado: (2022)

Discontinuing financial incentives for adherence to antipsychotic depot medication: long-term outcomes of a cluster randomised controlled trial
por: Priebe, Stefan, et al.
Publicado: (2016)

Switching antipsychotics to support the physical health of people with severe mental illness: a qualitative study of healthcare professionals’ perspectives
por: Nash, Annabel, et al.
Publicado: (2021)

Negative symptoms in schizophrenia: a study in a large clinical sample of patients using a novel automated method
por: Patel, Rashmi, et al.
Publicado: (2015)

Changes in antipsychotic drug usage and factors affecting the use of typical drugs based on nationwide health insurance data in South Korea
por: Lee, Sang Uk, et al.
Publicado: (2018)

Investigation of Non-invasive Continuous Body Temperature Measurements in a Clinical Setting Using an Adhesive Axillary Thermometer (SteadyTemp®)
por: Boyer, Johannes, et al.
Publicado: (2021)

Virtual care and COVID-19: A survey study of adoption, satisfaction and continuing education preferences of healthcare providers in Newfoundland and Labrador, Canada
por: Curran, Vernon R., et al.
Publicado: (2023)

Unwanted effects of treatments for depression in children and adolescents: a mapping of systematic reviews
por: Eidet, Lise Mette, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_amso5tf5ueevskt2pbkf0nourq